Status:
COMPLETED
Febrile Infant Diagnostic Assessment and Outcome Study
Lead Sponsor:
Queen's University, Belfast
Conditions:
Urinary Tract Infections
Meningitis
Eligibility:
All Genders
Up to 90 years
Brief Summary
Febrile infants under 3 months of age represent a high risk group for invasive bacterial infection (IBI) and UTI with approximately 10-20% having bacteremia, meningitis or urinary tract infection. The...
Detailed Description
Background Infants below three months of age are at high risk of invasive bacterial infections (IBI) and urinary tract infections (UTI). Recent studies have reported the combined rate of IBI and UTI ...
Eligibility Criteria
Inclusion
- All infants 90 days of age and under with a fever of greater than 38 Centigrade during their time in the Emergency Department (ED) or Assessment Unit (AU) or with a history of fever of greater than 38 Centigrade recorded by anyone via any thermometer type within the last 24 hours.
Exclusion
- None
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
2076 Patients enrolled
Trial Details
Trial ID
NCT05259683
Start Date
August 1 2022
End Date
December 31 2023
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen's University Belfast
Belfast, Antrim, United Kingdom, BT9 7BL